Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ackerman, A. L., Cresswell, P. (2004) Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5:678–684.
Allan, S. M., Rothwell, N. J. (2001) Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2:734–744.
Babbe, H., Roers, A., Waisman, A., et al. (2000) Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192:393–404.
Balashov, K. E., Rottman, J. B., Weiner, H. L., Hancock, W. W. (1999) CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. U S A 96:6873–6878.
Battistini, L., Piccio, L., Rossi, B., et al. (2003) CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1. Blood 101:4775–4782.
Baumann, N., Pham-Dinh, D. (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 81:871–927.
Becher, B., Durell, B. G., Miga, A. V., et al. (2001) The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J. Exp. Med. 193:967–974.
Ben-Nun, A., Wekerle, H., Cohen, I. R. (1981) The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11:195–199.
Bevan, M. J. (2004) Helping the CD8(+) T-cell response. Nat. Rev. Immunol. 4:595–602.
Biddison, W. E., Taub, D. D., Cruikshank, W. W., et al. (1997) Chemokine and matrix metalloproteinase secretion by myelin proteolipid protein-specific CD8+ T cells: potential roles in inflammation. J. Immunol. 158:3046–3053.
Bitsch, A., Schuchardt, J., Bunkowski, S., et al. (2000) Acute axonal injury in multiple sclerosis: correlation with demyelination and inflammation. Brain 123(Pt 6):1174–1183.
Boon, M., Nolte, I. M., Bruinenberg, M., et al. (2001) Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval between G511525 and D6S1666 using a new method of haplotype sharing analysis. Neurogenetics 3:221–230.
Booss, J., Esiri, M. M., Tourtellotte, W. W., Mason, D. Y. (1983) Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 62:219–232.
Brabb, T., von Dassow, P., Ordonez, N., et al. (2000) In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J. Exp. Med. 192:871–880.
Calzascia, T., Di Berardino-Besson, W., Wilmotte, R., et al. (2003) Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brain. J. Immunol. 171:2187–2191.
Calzascia, T., Masson, F., De Berardino-Besson, W., et al. (2005) Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs. Immunity 22:175–184.
Carson, M. J., Reilly, C. R., Sutcliffe, J. G., Lo, D. (1999) Disproportionate recruitment of CD8+ T cells into the central nervous system by professional antigen-presenting cells. Am. J. Pathol. 154:481–494.
Chang, T. T., Sobel, R. A., Wei, T., et al. (2003) Recovery from EAE is associated with decreased survival of encephalitogenic T cells in the CNS of B7–1/B7–2-deficient mice. Eur. J. Immunol. 33:2022–2032.
Christensen, J. E., Nansen, A., Moos, T., et al. (2004) Efficient T-cell surveillance of the CNS requires expression of the CXC chemokine receptor 3. J. Neurosci. 24:4849–4858.
Coles, A. J., Wing, M. G., Molyneux, P., et al. (1999) Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann. Neurol. 46:296–304.
Crawford, M. P., Yan, S. X., Ortega, S. B., et al. (2004) High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103:4222–4231.
DiLorenzo, T. P., Serreze, D. V. (2005) The good turned ugly: immunopathogenic basis for dianetogenic CD8+ T cells in NOD mice. Immunol. Rev. 204:250–263.
Dressel, A., Chin, J. L., Sette, A., et al. (1997) Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands. J. Immunol. 159:4943–4951.
Ebers, G. C., Sadovnick, A. D., Risch, N. J. (1995) A genetic basis for familial aggregation in multiple sclerosis: Canadian Collaborative Study Group. Nature 377:150–151.
Ebers, G. C., Kukay, K., Bulman, D. E., et al. (1996) A full genome search in multiple sclerosis. Nat. Genet. 13:472–476.
Ferguson, B., Matyszak, M. K., Esiri, M. M., Perry, V. H. (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120(Pt 3):393–399.
Fogdell-Hahn, A., Ligers, A., Gronning, M., et al. (2000) Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 55:140–148.
Ford, M. L., Evavold, B. D. (2005) Specificity, magnitude, and kinetics of MOG-specific CD8(+) T cell responses during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 35:76–85.
Friese, M. A., Fugger, L. (2005) Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain 128(Pt 8):1747–1763. Erratum in Brain 2005;128(Pt 9):2215.
Friese, M. A., Montalban, X., Wilcox, N., Bell, J. I., Martin, R., Fugger, L. (2006) The value of animal models for drug development in multiple sclerosis, Brain 129:1940–1952.
Gay, F. W., Drye, T. J., Dick, G. W., Esiri, M. M. (1997) The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis: identification and characterization of the primary demyelinating lesion. Brain 120(Pt 8):1461–1483.
Gobin, S. J., Montagne, L., Van Zutphen, M., et al. (2001) Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions. Glia 36:68–77.
Goverman, J., Perchellet, A., Huseby, E. S. (2005) The role of CD8(+) T cells in multiple sclerosis and its animal models. Curr. Drug Targets Inflamm. Allergy 4:239–245.
Greter, M., Heppner, F. L., Lemos, M. P., et al. (2005) Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11:328–334.
Gronski, M. A., Boulter, J. M., Moskophidis, D., et al. (2004) TCR affinity and negative regulation limit autoimmunity. Nat. Med. 10:1234–1239.
Harbo, H. F., Lie, B. A., Sawcer, S., et al. (2004) Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 63:237–247.
Hauser, S. L., Bhan, A. K., Gilles, F., et al. (1986) Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19:578–587.
Hayashi, T., Morimoto, C., Burks, J. S., et al. (1988) Dual-label immunocytochemistry of the active multiple sclerosis lesion: major histocompatibility complex and activation antigens. Ann. Neurol. 24:523–531.
Heath, W. R., Carbone, F. R. (2001) Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19:47–64.
Hemmer, B., Archelos, J. J., Hartung, H. P. (2002) New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 3:291–301.
Hernandez, J., Aung, S., Marquardt, K., Sherman, L. A. (2002) Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. J. Exp. Med. 196:323–333.
Hickey, W. F. (1999) Leukocyte traffic in the central nervous system: the participants and their roles. Semin. Immunol. 11:125–137.
Hickey, W. F., Kimura, H. (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290–292.
Hoftberger, R., Aboul-Enein, F., Brueck, W., et al. (2004) Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol. 14:43–50.
Hohlfeld, R., Wiendl, H. (2001) The ups and downs of multiple sclerosis therapeutics. Ann. Neurol 49:281–284.
Honma, K., Parker, K. C., Becker, K. G., et al. (1997) Identification of an epitope derived from human proteolipid protein that can induce autoreactive CD8+ cytotoxic T lymphocytes restricted by HLA-A3: evidence for cross-reactivity with an environmental microorganism. J. Neuroimmunol. 73:7–14.
Howard, L. M. Miga, A. J., Vanderlugt, C. L., et al. (1999) Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J. Clin. Invest. 103:281–290.
Huseby, E. S., Ohlen, C., Goverman, J. (1999) Cutting edge: myelin basic protein-specific cytotoxic T cell tolerance is maintained in vivo by a single dominant epitope in H-2k mice. J. Immunol. 163:1115–1118.
Huseby, E. S., Liggitt, D., Brabb, T., et al. (2001) A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 194:669–676.
Huseby, E. S., White, J., Crawford, F., et al. (2005) How the T cell repertoire becomes peptide and MHC specific. Cell 122:247–260.
Jacobsen, M., Cepok, S., Quak, E., et al. (2002) Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 125:538–550.
Jensen, J., Krakauer, M., Sellebjerg, F. (2001) Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosis. Eur. J. Neurol. 8:321–328.
Jersild, C., Svejgaard, A., Fog, T. (1972) HL-A antigens and multiple sclerosis. Lancet 1:1240–1241.
Jiang, H., Zhang, S. I., Pernis, B. (1992) Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256:1213–1215.
Joly, E., Mucke, L., Oldstone, M. B. (1991) Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253:1283–1285.
Jurewicz, A., Biddison, W. E., Antel, J. P. (1998) MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J. Immunol. 160:3056–3059.
Karman, J., Ling, C., Sandor, M., Fabry, Z. (2004) Initiation of immune responses in brain is promoted by local dendritic cells. J. Immunol. 173:2353–2361.
Kivisakk, P., Mahad D. J., Callahan, M. K., et al. (2003) Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl. Acad. Sci. U S A 100:8389–8394.
Kivisakk, P., Mahad, D. J., Callahan, M. K., et al. (2004) Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann. Neurol. 55:627–638.
Kleinschmidt-DeMasters, B. K., Tyler, K. L. (2005) Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N. Engl. J. Med. 353:369–374.
Koh, D. R., Fung-Leung, W. P., Ho, A., et al. (1992) Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 256:1210–1213.
Kornek, B., Storch, M. K., Weissert, R., et al. (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 157:267–276.
Krogsgaard, M., Wucherpfennig, K. W., Cannella, B., et al. (2000) Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85–99 complex. J. Exp. Med. 191:1395–1412.
Kuhlmann, T., Lingfeld, G., Bitsch, A., et al. (2002) Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125:2202–2212.
Kurts, C., Sutherland, R. M., Davey, G., et al. (1999) CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc. Natl. Acad. Sci. U S A 96:12703–12707.
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., et al. (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128:2705–2712.
Langer-Gould, A., Atlas, S. W., Green, A. J., et al. (2005) Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 353:375–381.
Laplaud, D. A., Ruiz, C., Wiertleewski, S., et al. (2004) Blood T-cell receptor beta chain transcriptome in multiple sclerosis: characterization of the T cells with altered CDR3 length distribution. Brain 127:981–995.
Lassmann, H. (1983) Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Schriftenr. Neurol. 25:1–135.
Lassmann, H., Ransohoff, R. M. (2004) The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal. Trends Immunol. 25:132–137.
Logunova, N. N., Viret, C., Pobezinsky, L. A., et al. (2005) Restricted MHC-peptide repertoire predisposes to autoimmunity. J. Exp. Med. 202:73–84.
Madsen, L. S., Andersson, E. C., Jansson, L., et al. (1999) A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat. Genet. 23:343–347.
Marrosu, M., Murru, M. R., Costa, G., et al. (1997) Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. Am. J. Hum. Genet. 61:454–457.
Marrosu, M. G., Murru, R., Murru, M. R., et al. (2001) Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum. Mol. Genet. 10:2907–2916.
McMahon, E. J., Bailey, S. L., Castenada, C. V., et al. (2005) Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11:335–339.
Medana, I., Li, Z., Flugel, A., et al. (2001a) Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity. J. Immunol. 167:674–681.
Medana, I., Martinic, M. A., Wekerle, H., Neumann, H. (2001b) Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am. J. Pathol. 159:809–815.
Mendel, I., Kerlero de Rosbo, N., Ben-Nun, A. (1996) Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice. Eur. J. Immunol. 26:2470–2479.
Miller, D. H., Khan, O. A., Sheremata, W. A., et al. (2003) A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 348:15–23.
Monaco, M. C., Shin, J., Major, E. O. (1998) JC virus infection in cells from lymphoid tissue. Dev. Biol. Stand. 94:115–122.
Muller, D. M., Pender, M. P., Greer, J. M. (2004) Chemokines and chemokine receptors: potential therapeutic targets in multiple sclerosis. Curr. Drug Targets Inflamm. Allergy 3:279–290.
Naito, S., Namerow, N., Mickey, M. R., Terasaki, P. I. (1972) Multiple sclerosis: association with HL-A3. Tissue Antigens 2:1–4.
Nepom, G. T., Erlich, H. (1991) MHC class-II molecules and autoimmunity. Annu. Rev. Immunol. 9:493–525.
Neumann, H., Cavalie, A., Jenne, D. E., Wekerle, H. (1995) Induction of MHC class I genes in neurons. Science 269:549–552.
Neumann, H., Schmidt, H., Cavalie, A., et al. (1997) Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha. J. Exp. Med. 185:305–316.
Neumann, H., Misgeld, T., Matsumuro, K., Wekerle, H. (1998) Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc. Natl. Acad. Sci. U S A 95:5779–5784.
Neumann, H., Medana, I. M., Bauer, J., Lassmann, H. (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25:313–319.
Niland, B., Banki, K., Biddison, W. E., Perl, A. (2005) CD8+ T cell-mediated HLA-A*0201-restricted cytotoxicity to transaldolase peptide 168–176 in patients with multiple sclerosis. J. Immunol. 175:8365–8378.
Odeberg, J., Piao, J. H., Samuelsson, E. B., et al. (2005) Low immunogenicity of in vitro-expanded human neural cells despite high MHC expression. J. Neuroimmunol. 161:1–11.
Oksenberg, J. R., Panzara, M. A., Begovich, A. B., et al. (1993) Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362:68–70.
Olerup, O., Hillert, J. (1991) HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 38:1–15.
Paolillo, A., Coles, A. J., Molyneux, P. D., et al. (1999) Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H. Neurology 53:751–757.
Pashenkov, M., Link, H. (2002) Dendritic cells and immune responses in the central nervous system. Trends Immunol. 23:69–70; author reply 70.
Pashenkov, M., Huang, Y. M., Kostulas, V., et al. (2001) Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain 124:480–492.
Pouly, S., Becher, B., Blain, M., Antel, J. P. (2000) Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. J. Neuropathol. Exp. Neurol. 59:280–286.
Rall, G. F., Mucke, L., Oldstone, M. B. (1995) Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo. J. Exp. Med. 182:1201–1212.
Ramakrishna, C., Stohlman, S. A., Atkinson, R. A., et al. (2004) Differential regulation of primary and secondary CD8+ T cells in the central nervous system. J. Immunol. 173:6265–6273.
Ransohoff, R. M., Estes, M. L. (1991) Astrocyte expression of major histocompatibility complex gene products in multiple sclerosis brain tissue obtained by stereotactic biopsy. Arch. Neurol. 48:1244–1246.
Ransohoff, R. M., Kivisakk, P., Kidd, G. (2003) Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3:569–581.
Rensing-Ehl, A., Malipiero, U., Irmler, M., et al. (1996) Neurons induced to express major histocompatibility complex class I antigen are killed via the perforin and not the Fas (APO-1/CD95) pathway. Eur. J. Immunol. 26:2271–2274.
Rioux, J. D., Abbas, A. K. (2005) Paths to understanding the genetic basis of autoimmune disease. Nature 435:584–589.
Rubio, J. P., Bahio, M., Butzkueven, H., et al. (2002) Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Am. J. Hum. Genet. 70:1125–1137.
Ruijs, T. C., Freedman, M. S., Grenier, Y. G., et al. (1990) Human oligodendrocytes are susceptible to cytolysis by major histocompatibility complex class I-restricted lymphocytes. J. Neuroimmunol. 27:89–97.
Scarpini, E., Galimberti, D., Baron, P., et al. (2002) IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease. J. Neurol. Sci. 195:41–46.
Seder, R. A., Ahmed, R. (2003) Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat. Immunol. 4:835–842.
Serafini, B., Columba-Cabezas, S., Di Rosa, F., Aloisi, F. (2000) Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 157:1991–2002.
Skulina, C., Schmidt, S., Dornmair, K., et al. (2004) Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc. Natl. Acad. Sci. U S A 101:2428–2433.
Smith, C. M., Wilson, N. S., Waithman, J., et al. (2004) Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity. Nat. Immunol. 5:1143–1148.
Sollid, L. M., Thorsby, E. (1993) HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 105:910–922.
Sollid, L. M., Markussen, G., Ek, J., et al. (1989) Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J. Exp. Med. 169:345–350.
Sriram, S., Steiner, I. (2005) Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann. Neurol. 58:939–945.
Stastny, P. (1978) Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N. Engl. J. Med. 298:869–871.
Steinman, L. (1999) Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 24:511–514.
Steinman, L. (2001) Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J. Exp. Med. 194:F27–30.
Su, S. B., Silver, P. B., Grajewski, R. S., et al. (2005) Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J. Immunol. 175:6303–6310.
Sun, D., Whitaker, J. N., Huang, Z., et al. (2001) Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166:7579–7587.
Sun, D., Zhang, Y., Wei, B., et al. (2003) Encephalitogenic activity of truncated myelin oligodendrocyte glycoprotein (MOG) peptides and their recognition by CD8+ MOG-specific T cells on oligomeric MHC class I molecules. Int. Immunol. 15:261–268.
Sun, J. C., Williams, M. A., Bevan, M. J. (2004) CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat. Immunol. 5:927–933.
Trapp, B. D., Peterson, J., Ransohoff, R. M., et al. (1998) Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:278–285.
Tsuchida, T., Parker, K. C., Turner, R. V., et al. (1994) Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides. Proc. Natl. Acad. Sci. U S A 91:10859–10863.
Tyznik, A. J., Sun, J. C., Bevan, M. J. (2004) The CD8 population in CD4-deficient mice is heavily contaminated with MHC class II-restricted T cells. J. Exp. Med. 199:559–565.
Ubogu, E. E., Cossoy, M. B., Ransohoff, R. M. (2005) The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 27:48–55.
Van Assche, G., Ban Ranst, M., Sciot, R., et al. (2005) Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn’s disease. N. Engl. J. Med. 353:362–368.
Van Oosten, B. W., Lai, M., Hodgkinson, S., et al. (1997) Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology 49:351–357.
Weller, R. O. (1998) Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J. Neuropathol. Exp. Neurol. 57:885–894.
Weninger, W., Manjunath, N., von Andrian, U. H. (2002) Migration and differentiation of CD8+ T cells. Immunol. Rev. 186:221–233.
Yednock, T. A., Cannon, C., Fritz, L. C., et al. (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356:63–66.
Zamvil, S., Nelson, P., Trotter, J., et al. (1985a) T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317:355–358.
Zamvil, S. S., Nelson, P. A., Mitchell, D. J., et al. (1985b) Encephalitogenic T cell clones specific for myelin basic protein: an unusual bias in antigen recognition. J. Exp. Med. 162:2107–2124.
Zang, Y. C., Li, S., Rivera, V. M., et al. (2004) Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J. Immunol. 172:5120–5127.
Zehntner, S. P., Brisebois, M., Tran, E., et al. (2003) Constitutive expression of a costimulatory ligand on antigen-presenting cells in the nervous system drives demyelinating disease. FASEB J. 17:1910–1912.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Friese, M.A., Fugger, L. (2007). CD8+ T Cells in Multiple Sclerosis. In: Zhang, J. (eds) Immune Regulation and Immunotherapy in Autoimmune Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-36003-4_13
Download citation
DOI: https://doi.org/10.1007/978-0-387-36003-4_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-36002-7
Online ISBN: 978-0-387-36003-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)